1,25-Dihydroxyvitamin D Resistance, Rickets, and Alopecia

    November 1984 in “ The American Journal of Medicine
    Ze’ev Hochberg, A Benderli, Joseph Levy, Pnina Vardi, Yosef Weisman, Theresa Chen, David Feldman
    New to cholecalciferol? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study observed that children with a genetically transmitted defect in the 1,25-dihydroxyvitamin D3 receptor experienced spontaneous healing of rickets as they aged, despite persistent mineral imbalances during treatment.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document described two unrelated families with four children affected by 1,25-dihydroxyvitamin D resistance, rickets, and alopecia. These children showed early severe rickets, hypocalcemia, hypophosphatemia, elevated serum alkaline phosphatase, and secondary hyperparathyroidism, along with total-body alopecia. Despite elevated serum levels of 1,25-dihydroxyvitamin D3 during treatment, the mineral disorder persisted, although secondary hyperparathyroidism and hypophosphatemia remitted. Skin biopsies revealed normal 1,25-dihydroxyvitamin D3 receptors in parents but undetectable receptors in affected children. Healing occurred spontaneously in older children, suggesting a genetically transmitted defect in the 1,25-dihydroxyvitamin D3 receptor, with mechanisms of healing remaining unclear.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results